findmyKOL
Clinical trialNCT03440814CompletedPhase 3Interventional

A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome

SponsorSoleno Therapeutics, Inc.Enrollment127Prader-Willi Syndrome
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United Kingdom
  • the Queen Elizabeth University

    Glasgow, Scottland, United Kingdom

  • Hull and East Yorkshire Hospitals Nhs Trust

    Hull, Yorkshire, United Kingdom

  • Birmingham Women'S and Children'S Hospital

    Birmingham, United Kingdom

  • Fulbourn Hospital

    Cambridge, United Kingdom

  • Aintree University Hospital Nhs Foundation Trust

    Liverpool, United Kingdom

  • Alder Hey Children'S Hospital Nhs Foundation Trust

    Liverpool, United Kingdom

  • Chelsea and Westminster Hospital

    London, United Kingdom

  • Hammersmith Hospital

    London, United Kingdom

  • Royal London Hospital

    London, United Kingdom

United States
  • University of California, Irvine

    Orange, California, United States

  • Stanford University

    Palo Alto, California, United States

  • Rady Children'S Hospital San Diego

    San Diego, California, United States

  • Children'S Hospital Colorado

    Aurora, Colorado, United States

  • University of Florida Gainesville

    Gainesville, Florida, United States

  • Emory Children'S Center

    Atlanta, Georgia, United States

  • Indiana University School of Medicine

    Indianapolis, Indiana, United States

  • Kansas University Medical Center

    Kansas City, Kansas, United States

  • National Institutes of Health Hatfield Clinical Research Center

    Bethesda, Maryland, United States

  • Boston Children'S Hospital

    Boston, Massachusetts, United States

  • Sparrow Clinical Research Institute

    Lansing, Michigan, United States

  • Children'S Minnesota

    Saint Paul, Minnesota, United States

  • St. Joseph'S University Medical Center

    Paterson, New Jersey, United States

  • Nyu Winthrop Hospital

    Mineola, New York, United States

  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio, United States

  • the Research Institute at Nationwide Children'S Hospital

    Columbus, Ohio, United States

  • Vanderbilt University

    Nashville, Tennessee, United States

  • Research Institute of Dallas

    Dallas, Texas, United States

  • University of Utah

    Salt Lake City, Utah, United States

  • Seattle Children'S Hospital

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
9 May 2018
Primary completion
1 May 2020
Completion
1 May 2020
Last update posted
21 Sept 2023
Registered enrollment
127
Registry id
NCT03440814

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.